Hikma Pharmaceuticals PLC Hikma Pharmaceuticals PLC

Hikma Pharmaceuticals PLC

HIK

Rang in Aktien #25542
Hikma Pharmaceuticals PLC is a global pharmaceutical enterprise involved in the... Hikma Pharmaceuticals PLC is a global pharmaceutical enterprise involved in the creation, production, promotion, and distribution of a wide array of generic, branded, and licensed medicinal solutions. These offerings are presented in various dosage formats, including solid, semi-solid, liquid, and injectable forms. The company's operations are strategically structured into three core segments: Injectables, Generics, and Branded. The Injectables division specializes in providing generic injectable medications, predominantly for hospital environments. Conversely, the Generics segment is responsible for supplying oral and other non-injectable generic pharmaceuticals to the consumer retail market. The Branded unit caters to both retail and hospital clients with its proprietary generic and in-licensed products. Hikma's comprehensive product portfolio addresses a broad spectrum of medical conditions, including anti-infective, cardiovascular, central nervous system, diabetes, oncology, pain management, and respiratory ailments. The firm boasts a substantial international presence, conducting business across the United Kingdom, the United States, the Middle East, North Africa, and various European countries. Founded in 1978, the company's corporate headquarters are situated in London, United Kingdom.
Aktienkurs
$22.27
Zuletzt synchronisiert: 2026-10-20
Marktkapitalisierung
$46.11M
Veränderung (1 Tag)
-1.50%
Veränderung (1 Jahr)
-54.15%
Land
GB
Handel Hikma Pharmaceuticals PLC (HIK)

Kategorie

Healthcare
Aktien-Split-Historie für Hikma Pharmaceuticals PLC (HIK)
Die Aktie Hikma Pharmaceuticals PLC (Symbol: HIK) durchlief insgesamt 0 Aktiensplits.
Der letzte Aktiensplit fand am Oct 21, 2026 statt.
Eine HIK-Aktie, die vor dem Oct 21, 2026 gekauft wurde, entspricht heute 0 HIK-Aktien.
Liste der Aktiensplits
Jahr Aktien-Split Multiplikator Kumulierter Multiplikator
Nicht genügend Daten für die angegebenen Daten.
Aktiensplits ähnlicher Unternehmen oder Wettbewerber